Press Releases


At Pulmatrix, we are committed to communicating clear and consistent information. Here we feature current and historic content concerning our science, our pipeline, and our corporate initiatives and achievements. Please check in often for the most recent press releases and information.

Advanced Search
  • Mar 16, 2015

    Santa Rosa, Ca., March --- March 16, 2015 – Ruthigen, Inc. (NASDAQ: RTGN) (“Ruthigen”), and Pulmatrix, Inc., (“Pulmatrix”), a Lexington, Massachusetts based clinical stage...

  • May 5, 2014
    Results Demonstrated the Enablement of High Drug Load Delivery with iSPERSE Dry Powder Delivery Technology

    Lexington, MA, May 5, 2014 – Pulmatrix today presented data at the 2014 Respiratory Drug Delivery Conference in Fajardo, Puerto Rico. The poster presentation includes development data on...

  • May 5, 2014
    Clinical Results Highlight Advantages of the iSPERSE Inhaled Dry Powder Delivery Platform over Conventional Lactose Blend Technologies

    Lexington, MA, May 5, 2014 – Pulmatrix today announced the successful completion and positive results of the second part of a two-part Phase 1B clinical study in chronic obstructive...

Show 5102550100 per page

print email rss
© 2015 Pulmatrix, Inc. All Rights Reservedhome   about pulmatrix   platform   pipeline   investors   careers   contact   site design